Xu, Y.; Cai, Q.; Zhao, C.; Zhang, W.; Xu, X.; Lin, H.; Lin, Y.; Chen, D.; Lin, S.; Jia, P.;
et al. Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation. Pharmaceuticals 2025, 18, 12.
https://doi.org/10.3390/ph18010012
AMA Style
Xu Y, Cai Q, Zhao C, Zhang W, Xu X, Lin H, Lin Y, Chen D, Lin S, Jia P,
et al. Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation. Pharmaceuticals. 2025; 18(1):12.
https://doi.org/10.3390/ph18010012
Chicago/Turabian Style
Xu, Yaoyao, Qiaoyan Cai, Chunyu Zhao, Weixiang Zhang, Xinting Xu, Haowei Lin, Yuxing Lin, Daxin Chen, Shan Lin, Peizhi Jia,
and et al. 2025. "Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation" Pharmaceuticals 18, no. 1: 12.
https://doi.org/10.3390/ph18010012
APA Style
Xu, Y., Cai, Q., Zhao, C., Zhang, W., Xu, X., Lin, H., Lin, Y., Chen, D., Lin, S., Jia, P., Wang, M., Zhang, L., & Lin, W.
(2025). Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation. Pharmaceuticals, 18(1), 12.
https://doi.org/10.3390/ph18010012